Latest filing published 20 Feb 2026 for Polaryx Therapeutics, Inc., €6,742.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -21.5%Entry US$2.47 · Close 22 Oct 2026 US$1.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
G. Michael Landis: trading record in brief
Filings by G. Michael Landis span 2 companies, the busiest being Lannett Co Inc and Polaryx Therapeutics, Inc. Over a trading history stretching from 29 October 2013 to 18 February 2026, the count stands at 57 filings.
The open-market side counts 1 purchase for €6,742 alongside 11 sales for €1.5M. The net balance comes to €1.5M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 36 share grants and 8 option exercises. In 2026 alone, the filings show 1 purchase and no sales.
On 20 February 2026 came the latest disclosure, an open-market purchase for €6,742 in Polaryx Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to G. Michael Landis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,867 shares@ US$2.7871100.0% of flowCommon StockSEC:0001213900-26-018845:0Canonical exit: 19 May 2026 (T+90)
- 392 shares@ US$7.0715.1% of flowCommon StockSEC:0001209191-20-040222:0
- 1,487 shares@ US$8.9844.6% of flowCommon StockSEC:0001209191-19-056619:0
- 222 shares@ US$8.936.6% of flowCommon StockSEC:0001209191-19-056022:0
- 76 shares@ US$5.001.3% of flowCommon StockSEC:0001209191-19-050541:0
- 12,500 shares0Restricted Common StockSEC:0001209191-19-043902:0
- 575 shares@ US$6.9813.3% of flowCommon StockSEC:0001209191-19-043902:1
- 118 shares@ US$6.552.6% of flowCommon StockSEC:0001209191-19-043737:0
- 3,234 shares0Restricted Common StockSEC:0001209191-19-041070:0
- 325 shares@ US$6.056.4% of flowCommon StockSEC:0001209191-19-041070:1
- 14,396 shares0Restricted Common StockSEC:0001209191-18-058528:0
- 216 shares@ US$5.363.2% of flowCommon StockSEC:0001209191-18-058074:0
- 74 shares@ US$5.001.0% of flowCommon StockSEC:0001209191-18-052037:0
- 5,735 shares0Restricted Common StockSEC:0001209191-18-044711:0
- 1 shares@ US$13.640.0% of flowCommon StockSEC:0001209191-18-044552:0
- 142 shares@ US$12.353.5% of flowCommon StockSEC:0001209191-18-044552:1
- 142 shares@ US$12.553.5% of flowCommon StockSEC:0001209191-18-044552:2
- 237 shares@ US$24.701.0% of flowCommon StockSEC:0001209191-17-060169:0
- 732 shares0Common StockSEC:0001209191-17-053821:0
- 154 shares@ US$20.600.5% of flowCommon StockSEC:0001209191-17-046543:0
- 298 shares@ US$17.340.9% of flowCommon StockSEC:0001209191-17-046222:0
- 154 shares@ US$21.500.6% of flowCommon StockSEC:0001209191-17-046222:1
- 52 shares@ US$21.500.2% of flowCommon StockSEC:0001209191-17-046222:2
- 276 shares@ US$18.741.0% of flowCommon StockSEC:0001209191-17-028222:0
- 234 shares@ US$19.000.8% of flowCommon StockSEC:0001209191-17-028222:1
25 of 57 declarations